News

The first-quarter earnings season for the banking sector begins this week, putting the spotlight on industry heavyweights like JPMorgan JPM and Morgan Stanley MS. As investors assess the investment

Workiva (WK) has been on a downward spiral lately with significant selling pressure. After declining 15% over the past four weeks, the stock looks well positioned for a trend reversal as it is now

Veeva Systems (VEEV) has been on a downward spiral lately with significant selling pressure. After declining 15.4% over the past four weeks, the stock looks well positioned for a trend reversal as

Angel Studios, Inc. (ANGX) has been beaten down lately with too much selling pressure. While the stock has lost 41.1% over the past four weeks, there is light at the end of the tunnel as it is now

YPF Sociedad Anonima (YPF) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, YPF crossed above the 20-day moving average

A downtrend has been apparent in Jack Henry (JKHY) lately with too much selling pressure. The stock has declined 12.8% over the past four weeks. However, given the fact that it is now in oversold

Guidewire Software (GWRE) has been beaten down lately with too much selling pressure. While the stock has lost 26.5% over the past four weeks, there is light at the end of the tunnel as it is now in

After reaching an important support level, Adecoagro (AGRO) could be a good stock pick from a technical perspective. AGRO surpassed resistance at the 20-day moving average, suggesting a short-term

Invesco IVZ announced its preliminary assets under management (AUM) of $2.16 trillion for March 2026, representing a 4.4% decrease from the previous month.For March, Invesco reported net long-term

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Goldman Sachs (GS) reported $17.23 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 14.4%. EPS of $17.55 for the same period compares to $14.12 a year

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

Shares of Aurora Cannabis ACB have lost 19% year to date compared with the industry‘s 15% decline, as shown in the chart below.

Image Source: Zacks Investment Research

The underperformance reflects

Eli Lilly LLY and Johnson & Johnson JNJ are leading U.S.-based healthcare players in the pharmaceutical and biotech space.

Both companies have a solid footprint across oncology, immunology and

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, April 13:

Lifetime Brands, Inc. LCUT: This company, which is a leading designer, marketer and